Coronavirus Update: Pfizer/BioNTech Vaccine Shows Six-Month, Variant Protection

The companies still plan to develop a variant-specific version, while J&J said it anticipates meeting vaccine supply goals despite a manufacturing mix-up.

COVID-19 vaccine
Pfizer/BioNTech announced six-month and variant data for BNT162b2, while J&J said it anticipates meeting its supply goals • Source: Shutterstock

More from COVID-19

More from Scrip